Focus: Sight Sciences is a focused medical device company specializing in ophthalmology surgical systems for glaucoma and dry eye treatment. The company operates in a specialized niche within eye care with precision surgical instruments and therapeutic delivery systems.
Profile data last refreshed 2h ago · AI intelligence enriched 1w ago
No open roles listed right now. Follow Sight Sciences to get notified when they start hiring — the background below is worth knowing for when they do.
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Generic vasodilator post-loss of exclusivity; represents legacy portfolio rather than core ophthalmology focus.
Help build intelligence for Sight Sciences
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Generated by Claude from Sight Sciences's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Generic vasodilator post-loss of exclusivity; represents legacy portfolio rather than core ophthalmology focus.
Topical antifungal approaching exclusivity cliff; off-label from core ophthalmology business.
Early-stage formulation variant; minimal relevance to company's primary ophthalmology strategy.
No open positions listed yet. Check their careers page directly.
Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/moSource: USCIS H-1B Employer Data Hub